Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

CorMedix Inc (CRMD) had Revenue of $39.74M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$39.74M
Net Income	$19.83M
Cost of Goods Sold	$1.86M
Gross Profit	$37.87M
Operating Expenses	$20.19M
Operating Income	$19.54M
Non-Operating Income/Expense	$0.81M
Pre-Tax Income	$20.35M
Normalized Pre-Tax Income	$20.35M
Income after Taxes	$19.83M
Income from Continuous Operations	$19.83M
Consolidated Net Income/Loss	$19.83M
Normalized Income after Taxes	$19.83M
EBIT	$19.54M
EBITDA	$19.75M
Weighted-Average Shares Outstanding (Basic)	67.93M
Weighted-Average Shares Outstanding (Diluted)	71.92M
Earnings per Share (EPS) (Basic)	$0.29
Earnings per Share (EPS) (Diluted)	$0.28
Balance Sheet Financials
Current Assets	$248.06M
Property, Plant, and Equipment	$1.64M
Long-Term Assets	$4.54M
Total Assets	$252.60M
Current Liabilities	$31.71M
Long-Term Debt	--
Long-Term Liabilities	$0.26M
Total Liabilities	$31.97M
Common Equity	$220.63M
Tangible Shareholders Equity	$218.89M
Shareholders Equity	$220.63M
Common Shares Outstanding	74.62M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$49.73M
Cash Flow from Investing Activities	$-20.41M
Cash Flow from Financial Activities	$89.34M
Beginning Cash	$40.76M
End Cash	$159.41M
Increase/Decrease in Cash	$118.66M
Stock-Based Compensation	$6.18M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	7.82
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	95.31%
Operating Margin	49.18%
EBIT Margin	49.18%
EBITDA Margin	--
Pre-Tax Profit Margin	51.21%
Profit Margin	49.90%
Free Cash Flow	$49.69M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.16
Inventory Turnover	0.19
Receiveable Turnover	0.93
Days Sales in Receivables	97.19
Return on Equity	8.99%
Return on Tangible Equity	9.06%
Return on Assets	7.85%
Return on Investments	8.99%
Book Value Per Share	$2.96
Free Cash Flow per Share	$0.69
Operating Cash Flow per Share	$0.69

Data from Zacks Investment Research, Inc.